{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:44:13Z","timestamp":1785545053528,"version":"3.56.0"},"reference-count":25,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite the existence of several regional registries in the United Kingdom, gaps in geographic coverage have limited the ability to produce accurate national estimates of incidence, prevalence, and regional variation for motor neuron disease (MND). To address these challenges, a comprehensive national register encompassing England, Wales, and Northern Ireland was established to support epidemiological studies, health care planning, and clinical research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The primary objective of the MND Register is to provide a centralized research database aggregating clinical and demographic data to facilitate high-quality research. Secondary objectives include estimating disease incidence and prevalence, identifying regional differences in care and survival, evaluating potential disease clustering, and supporting data linkage and clinical trial recruitment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Eligible patients are those aged 16 years or older with a confirmed MND diagnosis made by a consultant neurologist. Data are collected prospectively and retrospectively through standardized templates, available via Microsoft Access, Microsoft Excel, or the REDCap (Research Electronic Data Capture; Vanderbilt University) web platform, and include up to 34 demographic and clinical variables. Additional self-reported data can be contributed through the Telehealth in MND\u2013Research platform. All data are securely stored in the King\u2019s College London Trusted Research Environment, undergo standardized preprocessing, and may be linked to National Health Service and national datasets for epidemiological analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The register includes data on over 11,000 individuals with MND, of whom nearly 7000 are currently alive. Postcode data are available for more than 4300 patients, enabling future geospatial analyses. By October 2025, 60 clinical sites were participating in the register, with around 50 actively submitting data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The MND Register represents one of the largest national registries for MND worldwide, providing a robust foundation for epidemiological modeling, clinical research, and health care planning. Ongoing efforts to expand prospective data collection, improve completeness, and integrate digital tools will further enhance its impact and support national and international MND research collaborations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/86458","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:35:06Z","timestamp":1776162906000},"page":"e86458-e86458","source":"Crossref","is-referenced-by-count":0,"title":["The Motor Neuron Disease Register for England, Wales, and Northern Ireland: Protocol for a Population Register"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1072-665X","authenticated-orcid":false,"given":"Andrea","family":"Biondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0788-1424","authenticated-orcid":false,"given":"Elizabeth","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6395-4228","authenticated-orcid":false,"given":"Modupe","family":"Aggreh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0991-8561","authenticated-orcid":false,"given":"Edward","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5606-7316","authenticated-orcid":false,"given":"Amber","family":"Collingwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2545-1046","authenticated-orcid":false,"given":"Liam","family":"Knox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1650-9707","authenticated-orcid":false,"given":"Andrea","family":"Bredin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8048-0631","authenticated-orcid":false,"given":"David","family":"Setters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5490-1697","authenticated-orcid":false,"given":"Kevin","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4924-7712","authenticated-orcid":false,"given":"Ammar","family":"Al-Chalabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"5","key":"R1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","article-title":"Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model","volume":"17","author":"Westeneng","journal-title":"Lancet Neurol"},{"issue":"11","key":"R2","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/S1474-4422(14)70219-4","article-title":"Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study","volume":"13","author":"Al-Chalabi","journal-title":"Lancet Neurol"},{"issue":"11","key":"R3","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jamaneurol.2019.2044","article-title":"Lifetime risk and heritability of amyotrophic lateral sclerosis","volume":"76","author":"Ryan","journal-title":"JAMA Neurol"},{"issue":"12","key":"R4","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.1093\/brain\/awac279","article-title":"The impact of age on genetic testing decisions in amyotrophic lateral sclerosis","volume":"145","author":"Mehta","journal-title":"Brain (Bacau)"},{"issue":"12","key":"R5","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41588-021-00973-1","article-title":"Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology","volume":"53","author":"van Rheenen","journal-title":"Nat Genet"},{"issue":"3-4","key":"R6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/21678421.2019.1587629","article-title":"Predicting the future of ALS: the impact of demographic change and potential new treatments on the prevalence of ALS in the United Kingdom, 2020-2116","volume":"20","author":"Gowland","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"20","key":"R7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14207351","article-title":"Understanding long-term survival in ALS: a cohort study on subject characteristics and prognostic factors","volume":"14","author":"Pupillo","journal-title":"J Clin Med"},{"issue":"1","key":"R8","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02298-2","article-title":"National registry for amyotrophic lateral sclerosis: a systematic review for structuring population registries of motor neuron diseases","volume":"21","author":"Barbalho","journal-title":"BMC Neurol"},{"issue":"1-2","key":"R9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/21678421.2020.1812661","article-title":"Motor neuron disease register for England, Wales and Northern Ireland-an analysis of incidence in England","volume":"22","author":"Opie-Martin","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"5-6","key":"R10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1080\/21678421.2021.2004167","article-title":"Trends in survival of ALS from a population-based registry","volume":"23","author":"Bianchi","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"7","key":"R11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/jnnp-2016-314495","article-title":"The changing picture of amyotrophic lateral sclerosis: lessons from European registers","volume":"88","author":"Hardiman","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"R12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/pch\/pxx125","article-title":"The Canadian Neuromuscular Disease Registry: connecting patients to national and international research opportunities","volume":"23","author":"Wei","journal-title":"Paediatr Child Health"},{"issue":"7-8","key":"R13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/21678421.2018.1497065","article-title":"The Swedish motor neuron disease quality registry","volume":"19","author":"Longinetti","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0918-z","article-title":"The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage","volume":"13","author":"Ambrosini","journal-title":"Orphanet J Rare Dis"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2018.11.034","article-title":"Establishment and 12-month progress of the New Zealand motor neurone disease registry","volume":"60","author":"Walker","journal-title":"J Clin Neurosci"},{"key":"R16","unstructured":"Scottish MND register gets online. MND Scotland. Mar 29, 2026. URL: https:\/\/mndscotland.org.uk\/news\/scottish-mnd-register-gets-online\/ [Accessed 30-04-2026]"},{"key":"R17","unstructured":"MND Register. URL: https:\/\/mndregister.ac.uk [Accessed 27-10-2025]"},{"issue":"1-2","key":"R18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/s0022-510x(99)00210-5","article-title":"The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)","volume":"169","author":"Cedarbaum","journal-title":"J Neurol Sci"},{"issue":"1-2","key":"R19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3109\/21678421.2013.805784","article-title":"Screening for cognition and behaviour changes in ALS","volume":"15","author":"Abrahams","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"R20","unstructured":"Microsoft access \u2013 database software and applications. Microsoft. Oct 27, 2025. URL: https:\/\/www.microsoft.com\/en-us\/microsoft-365\/access [Accessed 30-04-2026]"},{"key":"R21","unstructured":"REDCap (Research Electronic Data Capture). Oct 27, 2025. URL: https:\/\/project-redcap.org [Accessed 30-04-2026]"},{"key":"R22","unstructured":"Telehealth in MND research (TiM-R). UK Motor Neuron Disease Research Institute. Mar 29, 2026. URL: https:\/\/ukmndri.org\/research\/understanding-the-patient-and-disease-process\/telehealth-in-mnd-research\/ [Accessed 30-04-2026]"},{"key":"R23","unstructured":"NHS Data Security and Protection Toolkit (DSPT). Oct 27, 2025. URL: https:\/\/www.dsptoolkit.nhs.uk [Accessed 30-04-2026]"},{"key":"R24","unstructured":"The Welsh Information Governance Toolkit. Digital Health and Care Wales (DHCW). Oct 27, 2025. URL: https:\/\/dhcw.nhs.wales\/ig\/information-governance\/welsh-information-governance-toolkit\/ [Accessed 30-04-2026]"},{"key":"R25","unstructured":"Appendix 1: section 251 of the national health service act 2006. NHS digital. URL: https:\/\/digital.nhs.uk\/services\/data-access-request-service-dars\/how-the-national-data-opt-out-affects-data-released-by-nhs-digital\/national-data-opt-out-guidance-for-researchers\/appendix-1-section-251-of-the-national-health-service-act-2006 [Accessed 18-05-2026]"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e86458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:25:30Z","timestamp":1785536730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e86458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":25,"URL":"https:\/\/doi.org\/10.2196\/86458","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"v15i5e86458"}}